Pfizer Limited Schedules Board Meeting on 3rd Nov'26 for Q2 Results
Pfizer Ltd 路 Intimation 路 03 Nov 2026, 5:30 am
Pfizer Limited Schedules Board Meeting on 3rd Nov'26 for Q2 Results Pfizer Limited has scheduled a Board of Directors meeting on 3rd Nov'26 to consider, approve, and take on record the unaudited financial results for the quarter and half-year ended 30th Sep'26. In compliance with SEBI insider trading regulations, the trading window for dealing in the company's shares remains closed and will reopen 48 hours after the public disclosure of the financial results.
Original exchange filing (PDF)
More announcements from Pfizer Ltd
- Please find enclosed unaudited financial results for the quarter and half year ended September 30, 2026 along with the limited review report. 路 03 Nov 2026
- Pfizer Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 03 Nov 2026
- Pfizer Limited has informed the Exchange about Board Meeting to be held on 03-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 . 路 03 Nov 2026
- This is to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Tuesday, November 3, 2026, inter alia, to consider, approve and take on record the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2026. 路 03 Nov 2026
- Intimation for order issued by the Deputy/Additional Commissioner of Income Tax Transfer Pricing. 路 29 Sept 2026
- Intimation regarding change in Senior Management Personnel of the Company. 路 18 Sept 2026
- Please find enclosed outcome of the Board Meeting held today i.e., September 7, 2026. 路 07 Sept 2026
- Please find enclosed outcome of the Board Meeting held today i.e., September 7, 2026. 路 07 Sept 2026
